Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
SAMUEL
Living with HIV and managing hypercholesterolaemia and impaired glucose tolerance while ageing with HIV
56 years of age | Male
- Reliably attends appointments
- Trusting of treatment recommendations
- Assumes current treatment is as "good as it gets"
MEDICAL HISTORY
- HIV diagnosis: 2014
- HIV treatment history
- 3 prior regimens
- Virally suppressed on TAF-based regimen
- Other relevant history:
- Hepatitis B negative
COMORBIDITIES
- High cholesterol
- Pre-diabetes
TREATMENT GOALS
- He wants to continue enjoying his life with his partner and friends while remaining undetectable
- He wishes to minimise any negative impacts of his HIV and comorbidities to ensure he can live a healthy life as he gets older.
SOPHIE
A woman of childbearing potential looking to reduce her exposure to accumulated toxicities and to live well with HIV
33 years of age | Female
- Feels empowered and secure after recently entering a committed relationship
- Newly optimistic: considering future goals and long-term health
- Largely keeps to her appointments, but has missed a few over the years
MEDICAL HISTORY
- HIV diagnosis: 2016
- HIV treatment history:
- 2 prior regimens
- No history of treatment failure
OTHER RELATED HISTORY
- Hepatitis B negative
- Currently takes a contraceptive pill
TREATMENT GOALS
- Motivated to stay on a treatment that will control her HIV and keep herself healthy for a long life ahead
- Wants to optimise treatment where possible to avoid long-term toxicities now that she is in a committed relationship and is planning for the future
GEORGE
Living with HIV and conscious of his hereditary risk of developing chronic renal disease
43 years of age | Male
- Engaged in his health and is open to taking fewer medicines if his HIV stays undetectable
- Conscious that people living with HIV are prone to develop comorbidities
- Concerned about the long-term effects of HIV medicines
- Seeks reassurance by searching for treatments and the experience of others
MEDICAL HISTORY
- HIV Diagnosis: 2008
- HIV treatment history:
- Virally suppressed on an INSTI-based 3-drug regimen
OTHER RELEVANT HISTORY
- Hepatitis B negative
- Family history of chronic kidney disease
TREATMENT GOALS
- Has always shown an interest in understanding his condition and the available treatment options, as he wants to ensure his HIV is optimally controlled
- He is aware of the associated comorbidity risks and wants to optimise his future health
Learn more about Dovato and why Dovato is a good option for patients like Samuel, Sophie and George
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
Dovato is a registered trade mark of the ViiV Healthcare group of companies or its licensor.
PM-IE-DLL-WCNT-230002 | Date of Preparation: December 2023
